5-Hydroxytryptamine and arachidonic acid metabolites modulate extensive platelet activation induced by collagen in cats in vivo
Open Access
- 1 April 1990
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 99 (4) , 631-636
- https://doi.org/10.1111/j.1476-5381.1990.tb12982.x
Abstract
1 The pathways contributing to the platelet adhesion/aggregation reaction elicited by collagen microfibrils, administered to cats in vivo, were analysed. 2 The intra-aortic infusion of collagen (100 μg kg−1 in 1 min) caused an extensive activation of platelets, as evidenced by the time-dependent drop of free platelet numbers in whole blood, and the increases of 5-hydroxyindoles (5-HI), 5-hydroxytryptamine (5-HT) and thromboxane B2 (TXB2) levels in plasma, prepared from effluent venous blood sampled from the inferior caval vein. 3 5-HT2 receptor blockade with ketanserin (0.63 mg kg−1 i.v., 10 min) and cyclo-oxygenase inhibition with aspirin (10 mg kg−1 i.v., 10 min) slightly attenuated the peak reduction of free platelets in whole blood in response to collagen without affecting changes in plasma 5-HI. Aspirin, but not ketanserin, reduced the collagen-induced changes in plasma TXB2, prostaglandin E2 (PGE2) and 6K-PGF1α. 4 Dual TXA2 synthetase inhibition/TXA2-prostaglandin endoperoxide receptor antagonism with ridogrel (5 mg kg−1 i.v., 10 min) halved the drop in free platelets, reduced the release of platelet 5-HI, inhibited the increase in plasma TXB2 and elevated that of 6K-PGF1α and PGE2 in response to collagen. 5 Combined treatment with ketanserin and aspirin reduced the collagen-induced drop of free platelets and the release of platelet 5-HI to a similar extent as ridogrel alone; plasma prostanoids were affected as with aspirin alone. 6 Combined administration of ketanserin and ridogrel virtually eliminated the collagen-induced platelet adhesion/aggregation response and release of 5-HI; prostanoids were affected as with ridogrel alone. 7 The results indicate that the interplay between 5-HT and arachidonic acid metabolites is causally involved in the platelet reaction to activation induced by collagen in cats in vivo.Keywords
This publication has 36 references indexed in Scilit:
- Platelet Activation in Unstable Coronary DiseaseNew England Journal of Medicine, 1986
- Correction by ketanserin of the platelet‐mediated inhibition of peripheral collateral circulation in the cat: Measurement of blood flow with radioactive microspheresDrug Development Research, 1986
- The human pharmacology of platelet inhibition: pharmacokinetics relevant to drug action.Circulation, 1985
- Experimental Coronary Artery Thrombosis in the Absence of Thromboxane A2 SynthesisJournal of Cardiovascular Pharmacology, 1985
- Platelet-vessel wall interactions: Implication of 5-hydroxytryptamine. A reviewInflammation Research, 1984
- Platelet activation by endogenous 5-hydroxytryptamine and histamine released by mast cell degranulation with compound 48/80 in the ratInflammation Research, 1983
- A thromboxane synthetase inhibitor reorients endoperoxide metabolism in whole blood towards prostacyclin and prostaglandin E2Thrombosis Research, 1982
- Synthesis of Prostacyclin from Platelet-derived Endoperoxides by Cultured Human Endothelial CellsJournal of Clinical Investigation, 1980
- A dominant role of thromboxane formation in secondary aggregation of plateletsNature, 1979
- Platelet aggregation in partially obstructed vessels and its elimination with aspirin.Circulation, 1976